PEOPLE - Changes at Boston Scientific:
This article was originally published in Clinica
Dr Philip Le Goff has been appointed group president of Boston Scientific's vascular businesses (Meadox, Medi-Tech and Target Therapeutics). He joins from Novartis Pharma. Additionally, the US company has appointed Michel Darnaud president of Boston Scientific Europe. He was previously president-Europe of Baxter International's Cardiovascular Group.